Antipsychotics

Alzheimer’s disease and dementia present profound challenges in cognitive and functional decline among the elderly. While not curative, antipsychotic medications are sometimes used to manage behavioral symptoms like agitation, aggression, and hallucinations that can arise in these conditions. However, their use in dementia care is controversial due to potential side effects, including increased risk of stroke, sedation, and accelerated cognitive decline. Non-pharmacological approaches such as structured routines, cognitive stimulation, and environmental modifications are preferred whenever possible. Careful consideration by healthcare providers is essential, weighing the risks and benefits to ensure the highest quality of life for patients while minimizing adverse effects. Ongoing research aims to refine treatment strategies, emphasizing personalized care approaches tailored to the unique needs and responses of individuals with Alzheimer’s disease and other forms of dementia.

Committee Members
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Jacqueline Tuppen

Jacqueline Tuppen

Cogs Club, United Kingdom
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Yong Xiao Wang

Yong Xiao Wang

Albany Medical College, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Kaoru Sakatani

Kaoru Sakatani

The University of Tokyo, Japan
Dementia 2023 Speakers
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Suren A Tatulian

Suren A Tatulian

University of Central Florida, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Constantina Mizis

Constantina Mizis

The Latino Alzheimer’s and Memory Disorders Alliance, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Paul Y Song

Paul Y Song

NKGen Biotech, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Marco Ruggiero

Marco Ruggiero

Silver Spring Sagl, Switzerland
Facebook
Watsapp